Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 380247, 10 pages
http://dx.doi.org/10.1155/2015/380247
Research Article

Low Magnesium Exacerbates Osteoporosis in Chronic Kidney Disease Patients with Diabetes

1Department of Community Health, Chia-Yi Christian Hospital, Chiayi 600, Taiwan
2Stem Cell Center, Department of Medical Research, Taichung Veterans General Hospital, Taichung 402, Taiwan
3Division of Nephrology, Department of Internal Medicine, Changhua Christian Medical Foundation Erlin Christian Hospital, Changhua 526, Taiwan

Received 16 October 2014; Revised 19 January 2015; Accepted 9 March 2015

Academic Editor: Francesco Pantano

Copyright © 2015 Jui-Hua Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. E. Lane, “Epidemiology, etiology, and diagnosis of osteoporosis,” American Journal of Obstetrics & Gynecology, vol. 194, no. 2, supplement, pp. S3–S11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. K. Rude, F. R. Singer, and H. E. Gruber, “Skeletal and hormonal effects of magnesium deficiency,” Journal of the American College of Nutrition, vol. 28, no. 2, pp. 131–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. B. S. Levine, M. Rodriguez, and A. J. Felsenfeld, “Serum calcium and bone: effect of PTH, phosphate, vitamin D and uremia,” Nefrologia, vol. 34, no. 5, pp. 658–669, 2014. View at Google Scholar
  4. D. Wlodarek, D. Glabska, A. Kolota, and et al, “Calcium intake and osteoporosis: the influence of calcium intake from dairy products on hip bone mineral density and fracture incidence—a population-based study in women over 55 years of age,” Public Health Nutrition, vol. 17, no. 2, pp. 383–389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Tomida, T. Hamano, S. Mikami et al., “Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients,” Bone, vol. 44, no. 4, pp. 678–683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Castiglioni, A. Cazzaniga, W. Albisetti, and J. A. M. Maier, “Magnesium and osteoporosis: current state of knowledge and future research directions,” Nutrients, vol. 5, no. 8, pp. 3022–3033, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. W. Gray, J. L. Omdahl, J. G. Ghazarian, and H. F. DeLuca, “25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties,” The Journal of Biological Chemistry, vol. 247, no. 23, pp. 7528–7532, 1972. View at Google Scholar · View at Scopus
  8. H. Matsuzaki, S.-I. Katsumata, Y. Kajita, and M. Miwa, “Magnesium deficiency regulates vitamin D metabolizing enzymes and type II sodium-phosphate cotransporter mRNA expression in rats,” Magnesium Research, vol. 26, no. 2, pp. 83–86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Stavroulopoulos, C. J. Porter, S. D. Roe, D. J. Hosking, and M. J. D. Cassidy, “Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4,” Nephrology, vol. 13, no. 1, pp. 63–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Rouached, S. El Kadiri Boutchich, A. M. Al Rifai, M. Garabédian, and A. Fournier, “Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease,” Kidney International, vol. 74, no. 3, pp. 389–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Moranne, M. Froissart, J. Rossert et al., “Timing of onset of CKD-related metabolic complications,” Journal of the American Society of Nephrology, vol. 20, no. 1, pp. 164–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. F. Navarro-González, C. Mora-Fernández, and J. García-Pérez, “Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis,” Seminars in Dialysis, vol. 22, no. 1, pp. 37–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Sakaguchi, T. Shoji, T. Hayashi et al., “Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease,” Diabetes Care, vol. 35, no. 7, pp. 1591–1597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Topf and P. T. Murray, “Hypomagnesemia and hypermagnesemia,” Reviews in Endocrine & Metabolic Disorders, vol. 4, no. 2, pp. 195–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Okuno, “Magnesium disorder and its clinical significance in chronic kidney disease,” Clinical Calcium, vol. 22, no. 8, pp. 1243–1249, 2012. View at Google Scholar · View at Scopus
  16. J. G. Gums, “Magnesium in cardiovascular and other disorders,” American Journal of Health-System Pharmacy, vol. 61, no. 15, pp. 1569–1576, 2004. View at Google Scholar · View at Scopus
  17. A. Navarrete-Cortes, J. L. Ble-Castillo, F. Guerrero-Romero et al., “No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia,” Magnesium Research, vol. 27, no. 2, pp. 48–56, 2014. View at Publisher · View at Google Scholar
  18. L. M. Giangregorio, W. D. Leslie, L. M. Lix et al., “FRAX underestimates fracture risk in patients with diabetes,” Journal of Bone and Mineral Research, vol. 27, no. 2, pp. 301–308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Dousdampanis, K. Trigka, and C. Fourtounas, “Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation,” Hemodialysis International, vol. 18, no. 4, pp. 730–739, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. F. J. A. Paula, C. M. M. Lanna, T. Shuhama, and M. C. Foss, “Effect of metabolic control on parathyroid hormone secretion in diabetic patients,” Brazilian Journal of Medical and Biological Research, vol. 34, no. 9, pp. 1139–1145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. R. M. Yoho, J. Frerichs, N. B. Dodson, R. Greenhagan, and S. Geletta, “A comparison of vitamin D levels in nondiabetic and diabetic patient populations,” Journal of the American Podiatric Medical Association, vol. 99, no. 1, pp. 35–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Yamamoto, T. Yamaguchi, K. Nawata, M. Yamauchi, and T. Sugimoto, “Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1277–1284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Dasgupta, D. Sarma, and U. K. Saikia, “Hypomagnesemia in type 2 diabetes mellitus,” Indian Journal of Endocrinology and Metabolism, vol. 16, no. 6, pp. 1000–1003, 2012. View at Publisher · View at Google Scholar
  24. R. K. Rude, J. S. Adams, E. Ryzen et al., “Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency,” The Journal of Clinical Endocrinology & Metabolism, vol. 61, no. 5, pp. 933–940, 1985. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Arnaud, “Update on the assessment of magnesium status,” The British Journal of Nutrition, vol. 99, supplement 3, pp. S24–S36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. R. Bailie and S. G. Massry, “Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview,” Pharmacotherapy, vol. 25, no. 12 I, pp. 1687–1707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Bordelon, M. V. Ghetu, and R. Langan, “Recognition and management of vitamin D deficiency,” American Family Physician, vol. 80, no. 8, pp. 841–846, 2009. View at Google Scholar · View at Scopus
  28. A. Levin, B. Hemmelgarn, B. Culleton et al., “Guidelines for the management of chronic kidney disease,” Canadian Medical Association Journal, vol. 179, no. 11, pp. 1154–1162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. M. Blake and I. Fogelman, “The role of DXA bone density scans in the diagnosis and treatment of osteoporosis,” Postgraduate Medical Journal, vol. 83, no. 982, pp. 509–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. D. K. Packham, T. P. Alves, J. P. Dwyer et al., “Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: Results from the DIAMETRIC (diabetes mellitus treatment for renal insufficiency consortium) database,” American Journal of Kidney Diseases, vol. 59, no. 1, pp. 75–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Doweiko and D. J. Nompleggi, “The role of albumin in human physiology and pathophysiology, part III: albumin and disease states,” Journal of Parenteral and Enteral Nutrition, vol. 15, no. 4, pp. 476–481, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Dewitte, A. Dhondt, M. Giri et al., “Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study,” Diabetes Care, vol. 27, no. 10, pp. 2503–2505, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. P.-C. T. Pham, P.-M. T. Pham, S. V. Pham, J. M. Miller, and P.-T. T. Pham, “Hypomagnesemia in patients with type 2 diabetes,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 2, pp. 366–373, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Kanbay, M. I. Yilmaz, M. Apetrii et al., “Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients,” American Journal of Nephrology, vol. 36, no. 3, pp. 228–237, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. F. Navarro, C. Mora, M. Macia, and J. Garcia, “Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 19, no. 5, pp. 455–461, 1999. View at Google Scholar · View at Scopus
  36. A. Baradaran and H. Nasri, “Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis,” Saudi Journal of Kidney Diseases and Transplantation, vol. 17, no. 3, pp. 344–350, 2006. View at Google Scholar · View at Scopus
  37. M. Ohya, S. Negi, T. Sakaguchi et al., “Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 10, pp. 3873–3878, 2014. View at Publisher · View at Google Scholar
  38. M. R. Khatami, E. Mirchi, Z. Khazaeipour, A. Abdollahi, and A. Jahanmardi, “Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients,” Iranian Journal of Kidney Diseases, vol. 7, no. 1, pp. 47–52, 2013. View at Google Scholar · View at Scopus
  39. R. K. Rude and H. E. Gruber, “Magnesium deficiency and osteoporosis: animal and human observations,” The Journal of Nutritional Biochemistry, vol. 15, no. 12, pp. 710–716, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. E. Rodríguez-Ortiz, A. Canalejo, C. Herencia et al., “Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration,” Nephrology Dialysis Transplantation, vol. 29, no. 2, pp. 282–289, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Reyes-García, P. Rozas-Moreno, G. López-Gallardo et al., “Serum levels of bone resorption markers are decreased in patients with type 2 diabetes,” Acta Diabetologica, vol. 50, no. 1, pp. 47–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Kanbay, D. Goldsmith, M. E. Uyar, F. Turgut, and A. Covic, “Magnesium in chronic kidney disease: challenges and opportunities,” Blood Purification, vol. 29, no. 3, pp. 280–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Bertinato, C. Lavergne, L. J. Plouffe, and H. A. El Niaj, “Small increases in dietary calcium above normal requirements exacerbate magnesium deficiency in rats fed a low magnesium diet,” Magnesium Research, vol. 27, no. 1, pp. 35–47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. Q. Dai, X. O. Shu, X. Deng et al., “Modifying effect of calcium/magnesium intake ratio and mortality: a population-based cohort study,” BMJ Open, vol. 3, no. 2, Article ID e002111, 7 pages, 2013. View at Publisher · View at Google Scholar
  45. J.-H. Huang, L.-C. Tsai, Y.-C. Chang, and F.-C. Cheng, “High or low calcium intake increases cardiovascular disease risks in older patients with type 2 diabetes,” Cardiovascular Diabetology, vol. 13, no. 1, article 120, 2014. View at Publisher · View at Google Scholar